Based on current experience in Australia and internationally, people at highest risk from monkeypox are gay, bisexual or other men who have sex with men (GBMSM) who have close and intimate contact with multiple partners.
ACT Health has secured a small initial supply of the JYNNEOS monkeypox vaccine. These vaccines will be prioritised for individuals who meet the initial priority criteria.
As more doses become available over the coming months, the priority groups for the vaccine will be expanded.
For further details about the initial priority criteria, please refer to the Chief Health Officer’s letter to clinicians and community service providers (12 August 2022).
Vaccination site and availability
Canberra Sexual Health Centre (CSHC) will be the ACT’s initial vaccination site. Vaccine will be available in the ACT from 16 August 2022.
ACT General Practitioners and community service providers can refer ACT residents (and NSW residents with established links to ACT healthcare providers) who meet vaccination priority criteria to CSHC for vaccine by using the monkeypox vaccine referral form.
For further details about JYNNEOS® monkeypox vaccine in the ACT please refer to the Chief Health Officer’s letter to clinicians and community service providers (12 August 2022).
If you suspect a patient has monkeypox
Clinicians are asked to be on the lookout for signs and symptoms consistent with monkeypox, particularly in returned travellers, and people who have had contact with a known case of monkeypox. A large proportion of cases detected overseas are among men who have sex with men, however cases are not limited to this group. Anyone who has prolonged close contact with someone who has monkeypox while they are infectious is at risk.
Monkeypox is a notifiable condition in the ACT. If monkeypox is suspected, clinicians should immediately contact ACT Health Communicable Disease Control on (02) 5124 9213 to discuss initial public health management.
For more information, including precautions that clinicians should take when seeing patients who may have monkeypox, see the CHO alert to clinicians for monkeypox.